SFEBES2007 Poster Presentations Clinical practice/governance and case reports (98 abstracts)
1Addisons Disease Self-Help Group, Guildford, United Kingdom; 2Churchill Hospital, Oxford, United Kingdom.
Autoimmune hypoadrenalism (Addisons disease) is a rare condition with a European prevalence of up to 140 per million1. It frequently occurs in association with other organ-specific autoimmune diseases, both endocrine and non-endocrine. These conditions are recognised to occur in the extended family, but their prevalence has been hard to determine, because of the rarity of the disease.
In 2003 we conducted the largest international survey of autoimmune hypoadrenalism to date (N=614). We asked patients to list all health conditions occurring in their extended family, including any apparently unrelated to their adrenal failure. Responses were compared to a well-matched control group (N=612).
The profile of associated conditions identified in males and females varied, reflecting the female predominance of autoimmune disease. The rate of maternal Addisons was 1.7% (6 cases), compared to just 0.2% (1 case) of paternal Addisons. Among grandparents, 0.9% of maternal grandmothers, 0.3% of paternal grandmothers; 0.2% of maternal and paternal grandfathers were reported to have Addisons. Addisons among siblings and children also showed a female preponderance: 3.4% of sisters and 2.8% of brothers; 1.2% of daughters and 0.8% of sons.
Hypothyroidism, Vitamin B12 deficiency and vitiligo were all found in the extended family. Hypothyroidism was reported in 19.2% of mothers, 4.3% of fathers, 9.4% of sisters, 3.7% of brothers, 5.8% of maternal grandmothers and 2% of paternal grandmothers. Vitamin B12 deficiency occurred in 5.4% of mothers, 2.8% of fathers, 2.6% of sisters and 1.4% of brothers. Vitiligo was reported in 1.7% of mothers, 1.4% of fathers, 2.6% of sisters and 1.1% of brothers.
These findings suggest that the immediate relatives of autoimmune Addisons patients should be screened for the possible development of associated autoimmune conditions.
1 Lovas & Husebye 2002.